Subsequently, elevated expression of EZH2 has already been demonstrated to promote cancer cell proliferation in multiple cancers, including bladder cancer [41], lung cancer [42], hepatocellular carcinoma [43] and gastric cancer [44]. The gene discussed is EZH2; the disease is hepatocellular carcinoma.